Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,433.76
+52.41
(+0.63%)
FTSE 250
20,645.38
+114.08
(+0.56%)
AIM
789.87
+6.17
(+0.79%)
GBP/EUR
1.1622
+0.0011
(+0.09%)
GBP/USD
1.2525
+0.0001
(+0.01%)
Bitcoin GBP
48,699.70
+7.23
(+0.01%)
MONEY
Best savings accounts that offer above inflation rates
How to earn the most interest on your savings
Provectus Biopharmaceuticals, Inc. (PXY.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.0450
0.0000
(0.00%)
At close: 02:55PM CEST
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,749
1,749
2,389
2,608
2,813
Selling general and administrative
1,732
1,732
2,025
2,055
2,145
Total operating expenses
2,910
2,910
3,391
4,636
4,932
Operating income or loss
-2,910
-2,910
-3,391
-4,636
-4,932
Interest expense
216.214
216.214
163.691
961.698
1,748
Total other income/expenses net
24.227
24.227
0.433
58.174
-1.273
Income before tax
-3,102
-3,102
-3,555
-5,540
-6,678
Income from continuing operations
-3,102
-3,102
-3,555
-5,540
-6,678
Net income
-3,102
-3,102
-3,555
-5,540
-6,678
Net income available to common shareholders
-3,102
-3,102
-3,555
-5,540
-6,678
Basic EPS
-0.01
-0.01
-0.01
-0.01
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.01
-0.02
Basic average shares
419,502
419,508
419,470
408,223
393,252
Diluted average shares
419,502
419,508
419,470
408,223
393,252
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.